Active

Midwinter Solutions (EU) Ltd

#632444 Private limited by shares

Midwinter Solutions (EU) Ltd is a private company limited by shares registered in Ireland on 21 August 2018 (company number 632444), based in Castleblayney, Co. Monaghan. Current status on the CRO register: Active.

Company Details

Registered Name MIDWINTER SOLUTIONS (EU) LIMITED
Company Number 632444
Company Type Private limited by shares
Type Code 1119
Status Normal

Important Dates

Registration Date 21 August 2018
Last Annual Return 9 July 2025
Last Accounts Filed 28 February 2025

Industry Classification (NACE)

NACE Code: 86.9

Registered Address

Everington Suite

UNIT 3

DRUMILLARD RETAIL PARK, MONAGHAN ROAD

CASTLEBLAYNEY,MONAGHAN

A75TP99

Contact Details

Phone Number Unknown
Email Address Unknown

Company Website

Company Description

Midwinter Solutions (EU) Limited is a specialist provider of end‑to‑end supply services for clinical trials. Drawing on deep expertise in trial logistics, the company partners with pharmaceutical and biotech organisations to ensure that investigational medicines are sourced, stored and distributed with the highest levels of precision, compliance and reliability.

Their core offering spans three tightly integrated pillars. The Sourcing and Supply team designs strategic sourcing plans and taps a global network of audited providers to guarantee uninterrupted access to essential medications. Storage and Distribution is delivered from state‑of‑the‑art, fully compliant facilities strategically located across the UK, Ireland, Germany and the United States, enabling temperature‑controlled handling and rapid fulfilment. In addition, Midwinter’s GMP Services provide bespoke packaging and labelling solutions that meet the unique regulatory and operational demands of each trial.

Midwinter positions itself as a proactive, knowledgeable partner, committed to transparent communication, timely responses and uncompromising quality. By combining unrivalled expertise with specialised facilities, the company helps clinical‑trial teams accelerate their programmes while safeguarding patient safety and data integrity.